• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 19th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
A 3D-printed miniature model of U.S. President Donald Trump with the National Institutes of Health (NIH) logo in the background is seen in this illustration taken April 23, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
A 3D-printed miniature model of U.S. President Donald Trump with the National Institutes of Health (NIH) logo in the background is seen in this illustration taken April 23, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
The patient's entrance at the National Institutes of Health is shown in Bethesda, Maryland October 16, 2014.  REUTERS/Gary Cameron/File Photo
The patient's entrance at the National Institutes of Health is shown in Bethesda, Maryland October 16, 2014. REUTERS/Gary Cameron/File Photo
Home
Business
Healthcare & Pharmaceuticals

Trump administration health research cuts total $1.8 billion, analysis finds

May 8th, 2025 | 18:53 PM BUSINESS Healthcare & Pharmaceuticals 2

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

West Nile virus outbreak kills four in North Macedonia 
Moderna shares double as cancer vaccine data rekindles investor hopes
China's top drugmaker Hengrui sees profit growth squeezed by bulk-buying programs
France recorded 1,243 excess deaths during July heatwaves
By Nancy Lapid

In a roughly five-week period this year, the U.S. National Institutes of Health terminated $1.81 billion in medical research funding, according to a new analysis.

Between February 28 and April 8, the NIH canceled 694 grants in response to the Trump administration's policy shifts and its efforts to shrink the federal budget, the authors of the analysis published on Thursday in JAMA found.

That number included 128 grants administered by the National Institute of Mental Health and 77 administered by the National Institute on Minority Health and Health Disparities.

The terminated funding was highest for the National Institute of Allergy and Infectious Diseases at nearly $506 million.

Cuts at the minority health agency totaling nearly $224 million accounted for nearly one-third of its previously active funding.

Last month, researchers sued to secure reinstatement of NIH grants that funded research on topics like LGBTQ health, COVID-19 and vaccine hesitancy that were canceled as part of an "ideological purge."

One termination letter from the NIH seen by Reuters in mid-March told researchers their study investigating changes in gene functions in different populations was “incompatible with agency priorities and no modification... could align the project with agency priorities.”

Across 210 recipient institutions, Columbia University saw the highest number of terminated grants, at 157, according to the new report. The Trump administration has been at odds with Columbia over what it has said was antisemitic harassment, as well as pro-Palestinian protests, around the school's New York City campus.

Johns Hopkins University, Yale University, Emory University, University of Michigan, Northwestern University, University of California San Francisco and University of Miami each had between 12 and 19 grants terminated.

Larger-than-average grants were also more likely to be terminated, the analysis suggested.

Although most of the terminated grants were funding research projects, 20% were funding researchers’ training or career development.

Next year, the White House wants to reduce U.S. health spending by more than 25%. The Trump administration last week proposed to cut the NIH budget by $18 billion, leaving it with $27 billion.

The authors of the analysis used the Tracking Accountability in Government Grants System database to identify all grants awarded by the U.S. Department of Health and Human Services that were terminated since the start of the current Trump administration in January. The NIH falls under HHS purview.

  • Topic
  • USA
  • CUTS (PIX)
  • TRUMP/HEALTH
Facebook Twitter Google+ LinkedIn Pinterest
Previous article West Nile virus outbreak kills four in North Macedonia 

Related Posts

Healthcare & Pharmaceuticals
August 19th, 2026

West Nile virus outbreak kills four in North Macedonia 

Healthcare & Pharmaceuticals
August 19th, 2026

Moderna shares double as cancer vaccine data rekindles investor hopes

Healthcare & Pharmaceuticals
August 19th, 2026

China's top drugmaker Hengrui sees profit growth squeezed by bulk-buying...

Healthcare & Pharmaceuticals
August 19th, 2026

France recorded 1,243 excess deaths during July heatwaves

Healthcare & Pharmaceuticals
August 19th, 2026

Platelets can be chilled and stored for weeks, not days, study shows

Healthcare & Pharmaceuticals
August 19th, 2026

Lundbeck sees no slowdown in key drugs despite cautious 2026 outlook, CE...

The Wire
Aug 19th 3 h ago
Government

DOJ argues Comey novel shows he knew ‘86 47’ post was a thr...

Aug 19th 3 h ago
Business

Fed policymakers' inflation concerns increased at July meet...

Aug 19th 3 h ago
Sports

Swiss rider Poncini dies in Manx GP qualifying

Aug 19th 3 h ago
Business

Amazon plans drone delivery expansion to about 500 US local...

Aug 19th 3 h ago
Litigation

Abbott settles appeal over $495 million infant formula verd...

TRENDING ON FINANCETIME
Aug 19th, 2026 Sports

Mets' Jorge Polanco (ankle) to have season-ending surgery

Aug 19th, 2026 Sports

Reports: Phillies sign free agent LHP Nestor Cortes

Aug 19th, 2026 Business

US CFTC seeks comment on compute derivatives as AI demand grows

Aug 19th, 2026 Technology

Payments firm Stripe to buy AI developer platform OpenRouter

Aug 19th, 2026 Government

ABC says intimidation by Trump's FCC forced programming changes

Markets-Sectors
ENERGY -0.01%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT